SOCAL biotech giant to buy rival for $1.1B; an article from Los Angeles Business from bizjournals
| ||
|
This article was sent to you by Jeffrey Allen (ir@globalcrossroadscapital.com): Amgen to buy Micromet for $1.16 billionPublished: January 26, 2012 Micromet Inc. has agreed to be acquired by biotech giant Amgen in a worth more than $1.1 billion. Thousand Oaks-based Amgen said in a statement Thursday that directors of both companies had unanimously agreed to a transaction that would pay stockholders of Rockville, Md.-based Micromet $11 per share in cash for all outstanding shares. |
||
|
Related Articles:
-
Titan Biotech, manufacture biological products meeting the requirements ranging from Protein... Read Full Story » -
by ILRI A New Way to Vanquish Biotechnology Products Deficit Nanotechnology researchers are... Read Full Story » -
Located in Mississauga, Ontario, Therapure Biopharma is an integrated biopharmaceutical company... Read Full Story » -
Therapeutic Protein Drug Products: Practical Approaches in the Laboratory, Manufacturing, and... Read Full Story » -
Therapeutic Protein Drug Products: Practical Approaches in the Laboratory, Manufacturing, and... Read Full Story »
Comments
